Insights into Growth Factors in Liver Carcinogenesis and Regeneration: An Ongoing Debate on Minimizing Cancer Recurrence after Liver Resection
Metadata
Show full item recordAuthor
Álvarez Mercado, Ana IsabelEditorial
MDPI
Materia
Liver cancer Liver resection Growth factors Regeneration Hepatocyte growth factor Insulin-like growth factor-1 Epidermal growth factor
Date
2021-09-04Referencia bibliográfica
Álvarez-Mercado, A.I... [et al.]. Insights into Growth Factors in Liver Carcinogenesis and Regeneration: An Ongoing Debate on Minimizing Cancer Recurrence after Liver Resection. Biomedicines 2021, 9, 1158. [https://doi.org/10.3390/biomedicines9091158]
Sponsorship
Ministerio de Ciencia, Innovacion y Universidades Madrid, Spain RTI2018-095114-B-I00; European Union (Fondos FEDER, "una manera de hacer Europa"); General Electric; Secretaria d' Universitats I Recerca del Departament d' Economia I Coneixement Barcelona, Spain 2017_SGR_551; COST action Programs CA17103 CA17112 CA17121 CA17126; Consejo Nacional de Ciencia y Tecnologia (CONACyT); Fondo Sectorial de Investigacion para la Educacion, Mexico 257743; FCT (Fundacio Catalana de Trasplantament), SpainAbstract
Hepatocellular carcinoma has become a leading cause of cancer-associated mortality
throughout the world, and is of great concern. Currently used chemotherapeutic drugs in the
treatment of hepatocellular carcinoma lead to severe side effects, thus underscoring the need for
further research to develop novel and safer therapies. Liver resection in cancer patients is routinely
performed. After partial resection, liver regeneration is a perfectly calibrated response apparently
sensed by the body’s required liver function. This process hinges on the effect of several growth
factors, among other molecules. However, dysregulation of growth factor signals also leads to
growth signaling autonomy and tumor progression, so control of growth factor expression may
prevent tumor progression. This review describes the role of some of the main growth factors whose
dysregulation promotes liver tumor progression, and are also key in regenerating the remaining liver
following resection. We herein summarize and discuss studies focused on partial hepatectomy and
liver carcinogenesis, referring to hepatocyte growth factor, insulin-like growth factor, and epidermal
growth factor, as well as their suitability as targets in the treatment of hepatocellular carcinoma.
Finally, and given that drugs remain one of the mainstay treatment options in liver carcinogenesis,
we have reviewed the current pharmacological approaches approved for clinical use or research
targeting these factors.
Collections
Related items
Showing items related by title, author, creator and subject.
-
Tratamiento de la toxicidad cutánea secundaria al tratamiento radioterápico con una crema basada en sH oligopeptide-1 (epidermal growth factor-egf): un estudio piloto
Seral-Gajón, Antonio Luis; Carreras-Sospedra, Ana; López-Jimeno, Carla; Viedma-Pastor, Mariano; Russo, Gabriella; [et al.] (2018-08-31)